The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca

References

• JohnsonMEMurphyPJChanges in the tear film and ocular surface from dry eye syndromeProg Retin Eye Res2004234497415219877
   PubMed Web of Science ®Google Scholar
• PflugfelderSCAntiinflammatory therapy for dry eyeAm J Ohthalmol200413733742
   PubMed Web of Science ®Google Scholar
• LempMAReport of the National Eye Institute/Industry workshop on clinical trials in dry eyesCLAO J199521221328565190
   PubMedGoogle Scholar
• McCartyCABansalAKLivingstonPMThe epidemiology of dry eye in Melbourne, AustraliaOphthalmology19981051114199627665
   PubMed Web of Science ®Google Scholar
• BjerrumKBKeratoconjunctivitis sicca and primary Sjögren’s syndrome in a Danish population aged 30–60 yearsActa Ophthalmol Scand19977528169253975
   PubMedGoogle Scholar
• ScheinODMunozBTielschJMPrevalence of dry eye among the elderlyAm J Ophthalmol199712472389402817
   PubMed Web of Science ®Google Scholar
• MossSEKleinRKleinBEPrevalence of and risk factors for dry eye syndromeArch Ophthalmol20001181264810980773
   PubMed Web of Science ®Google Scholar
• SternMEBeuermanRWFoxRIThe pathology of dry eye: the interaction between the ocular surface and lacrimal glandsCornea19981758499820935
   PubMed Web of Science ®Google Scholar
• GaoJSchwalbTAAddeoJVThe role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapyCornea199817654639820947
   PubMed Web of Science ®Google Scholar
• KunertKSTisdaleASSternMEAnalysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytesArch Ophthalmol200011814899611074805
   PubMed Web of Science ®Google Scholar
• SternMEGaoJSchwalbTAConjunctival T-cell subpopulations in Sjögren’s and non-Sjögren’s patients with dry eyeInvest Ophthalmol Vis Sci20024326091412147592
   PubMed Web of Science ®Google Scholar
• ZoukhriDEffect of inflammation on lacrimal gland functionExp Eye Res2006828859816309672
   PubMed Web of Science ®Google Scholar
• FoxRIPathogenesis of Sjögren’s syndromeRheum Dis Clin North Am199218517381323135
   PubMed Web of Science ®Google Scholar
• FoxRISjögren’s syndromeLancet20053663213116039337
   PubMed Web of Science ®Google Scholar
• VitaliCBombardieriSJonssonRClassification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnn Rheum Dis200261554812006334
   PubMed Web of Science ®Google Scholar
• ChenQLiXHeWThe epitope study of alpha-fodrin autoantibody in primary Sjögren’s syndromeClin Exp Immunol200714949750317614976
   PubMed Web of Science ®Google Scholar
• BacmanSPerez LeirosCSterin-BordaLAutoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren’s syndromeClin Exp Immunol199610445499099930
   PubMed Web of Science ®Google Scholar
• RoutsiasJGTzioufasAGSjögren’s syndrome-study of autoantigens and autoantibodiesClin Rev Allergy Immunol2007322385117992591
   PubMed Web of Science ®Google Scholar
• ManoussakisMNTzioufasAGPangePJESerologic profiles in subgroups of patients with Sjögren’s syndromeScand J Rheumatol1986618992
   Google Scholar
• YavuzSTokerEBicakcigilMComparative analysis of auto-antibodies against a-fodrin n serum, tear fluid, and saliva from patients with Sjögren’s syndromeJ Rheumatol20063312899216821267
   PubMed Web of Science ®Google Scholar
• WitteTMatthiasTBierwirthJAntibodies against alpha-fodrin are associated with sicca syndrome in the general populationAnn N Y Acad Sci200711084141717894005
   PubMed Web of Science ®Google Scholar
• TilchDASchäferHGWinterRDiagnostics of Sjögren’s syndrome by means of anti-alpha-fodrin antibodyKlin Monatsbl Augenheilkd20072244273017516374
   PubMed Web of Science ®Google Scholar
• TokerEYavuzSDireskeneliHAnti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren’s syndromeBr J Ophthalmology2004883847
   PubMed Web of Science ®Google Scholar
• BacmanSBerraASterin-BordaLMuscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndromeInvest Ophthalmol Vis Sci200142321711157861
   PubMed Web of Science ®Google Scholar
• WatermanSAGordonTPRischmuellerMInhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndromeArthritis Rheum20004316475410902771
   PubMed Web of Science ®Google Scholar
• BeauregardCBrandtPCChiouGCInduction of nitric oxide synthase and over-production of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cellsExp Eye Res2003771091412823994
   PubMed Web of Science ®Google Scholar
• BeauregardCBrandtPDown regulation of interleukin-1beta-induced nitric oxide production in lacrimal gland acinar cells by sex steroidsCurr Eye Res200429596615370368
   PubMed Web of Science ®Google Scholar
• ZoukhriDMacariEChoiSHc-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretionJ Neurochem2006961263516300639
   PubMed Web of Science ®Google Scholar
• JonesNPSarcoidosisCurr Opin Ophthalmol200213393612441843
   PubMedGoogle Scholar
• BaughmanRPLowerEEdu BoisRMSarcoidosisLancet200;36111111812672326
   PubMed Web of Science ®Google Scholar
• PrabhakaranVCSaeedPEsmaeliBOrbital and adnexal sarcoidosisArch Ophthalmol200712516576218071118
   PubMedGoogle Scholar
• HeiligenhausAWefelmeyerESchrenkMTear-film deficiencies in patients with sarcoidosis;clinical study of 56 patientsKlin Monatsbl Augenheilkd2002219502612195315
   PubMed Web of Science ®Google Scholar
• MargolisRLowderCYSarcoidosisCurr Opin Ophthalmol200718470518162998
   PubMed Web of Science ®Google Scholar
• ZisselGPrasseAMüller-QuernheimJSarcoidosis – immunopathogenetic conceptsSemin Respir Crit Care Med20072831417330188
   PubMed Web of Science ®Google Scholar
• TakeuchiMOh-IKSuzukiJElevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosisInvest Ophthalmol Vis Sci2006471063816505042
   PubMed Web of Science ®Google Scholar
• HataMSugisakiKMiyazakiECirculating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markersIntern Med20074613879317827837
   PubMed Web of Science ®Google Scholar
• AgostiniCMeneghinASemenzatoGT-lymphocytes and cytokines in sarcoidosisCurr Opin Pulm Med200284354012172449
   PubMed Web of Science ®Google Scholar
• BaughmanRPIannuzziMTumour necrosis factor in sarcoidosis and its potential for targeted therapyBioDrugs2003174253114614765
   PubMed Web of Science ®Google Scholar
• DaiHGuzmanJChenBProduction of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitisChest2005127251615653992
   PubMed Web of Science ®Google Scholar
• KansuEThe pathophysiology of chronic graft-versus-host diseaseInt J Hematol2004792091515168586
   PubMed Web of Science ®Google Scholar
• IchikiYBowlusCLShimodaST cell immunity and graft-versus-host disease (GVHD)Autoimmun Rev200651916338205
   PubMed Web of Science ®Google Scholar
• OgawaYKuwanaMDry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantationCornea200322192712502942
   PubMed Web of Science ®Google Scholar
• OgawaYYamazakiKKuwanaMA significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHDInvest Ophthalmol Vis Sci2001421111911133855
   PubMed Web of Science ®Google Scholar
• AntinJHFerraraJLCytokine dysregulation and acute graft-versus-host diseaseBlood199280296481467511
   PubMed Web of Science ®Google Scholar
• MossSEKleinRKleinBEIncidence of dry eye in an older populationArch Ophthalmol20041223697315006852
   PubMed Web of Science ®Google Scholar
• SchaumbergDASullivanDABuringJEPrevalence of dry eye syndrome among US womenAm J Ophthalmol20031363182612888056
   PubMed Web of Science ®Google Scholar
• RíosJDHorikawaYChenLLAge-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory responseExp Eye Res2005804779115781275
   PubMed Web of Science ®Google Scholar
• DraperCEAdeghateELawrencePAAge-related changes in morphology and secretory responses of male rat lacrimal glandJ Auton Nerv Syst199869173839696274
   PubMedGoogle Scholar
• BaudouinCThe pathology of dry eyeSurv Ophthalmol200145Suppl 221120
   PubMed Web of Science ®Google Scholar
• CorralesRMVillarrealAFarleyWStrain-related cytokine profiles on the murine ocular surface in response to desiccating stressCornea2007265798417525655
   PubMed Web of Science ®Google Scholar
• LiDQPflugfelderSCMatrix metalloproteinases in corneal inflammationOcul Surf20053Suppl 4198202
   Web of Science ®Google Scholar
• NakamuraSShibuyaMNakashimaHInvolvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eyeInvest Ophthalmol Vis Sci2007481552817389484
   PubMed Web of Science ®Google Scholar
• SolomonADursunDLiuZPro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye diseaseInvest Ophthalmol Vis Sci20014222839211527941
   PubMed Web of Science ®Google Scholar
• CejkováJArdanTSimonováZNitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren’s syndrome)Nitric Oxide20071710717600738
   PubMed Web of Science ®Google Scholar
• PaulAWilsonSBelhamCMStress-activated protein kinases: activation, regulation and functionCell Signal19979403109376221
   PubMed Web of Science ®Google Scholar
• PflugfelderSCde PaivaCSTongLStress-activated protein kinase signaling pathways in dry eye and ocular surface diseaseOcul Surf20053Suppl 41547
   Web of Science ®Google Scholar
• LuoLLiDQDoshiAExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthalmol Vis Sci200445429330115557435
   PubMed Web of Science ®Google Scholar
• LiDQLuoLChenZJNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cellsExp Eye Res2006825889616202406
   PubMed Web of Science ®Google Scholar
• De PaivaCSCorralesRMVillarrealALCorticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eyeExp Eye Res2006835263516643899
   PubMed Web of Science ®Google Scholar
• GipsonIKArgüesoPRole of mucins in the function of the corneal and conjunctival epitheliaInt Rev Cytol200323114914713002
   PubMed Web of Science ®Google Scholar
• GipsonIKHoriYArgüesoPCharacter of ocular surface mucins and their alteration in dry eye diseaseOcul Surf200421314817216084
   PubMedGoogle Scholar
• DanjoYWatanabeHTisdaleASAlteration of mucin in human conjunctival epithelia in dry eyeInvest Ophthalmol Vis Sci199839260299856770
   PubMed Web of Science ®Google Scholar
• SommerAEffects of vitamin A deficiency on the ocular surfaceOphthalmology1983905926006604247
   PubMed Web of Science ®Google Scholar
• van SettenGBViinikkaLTervoTEpidermal growth factor is a constant component of normal human tear fluidGraefes Arch Clin Exp Ophthalmol198922718472785946
   PubMed Web of Science ®Google Scholar
• McCulleyJPShineWEMeibomian gland function and the tear lipid layerOcul Surf200319710617075642
   PubMedGoogle Scholar
• ShineWEMcCulleyJPKeratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormalityArch Ophthalmol1998116849529682696
   PubMedGoogle Scholar
• LobefaloLD’AntonioEColangeloLDry eye in allergic conjunctivitis: role of inflammatory infiltrateInt J Immunopathol Pharmacol199912133712783641
   PubMed Web of Science ®Google Scholar
• GreinerJVPeaceDGBairdRSEffects of eye rubbing on the conjunctiva as a model of ocular inflammationAm J Ophthalmol198510045504014379
   PubMed Web of Science ®Google Scholar
• NussenblattRBPalestineAGCyclosporin: immunology, pharmacology, and therapeutic usesSurv Ophthalmol198631159693544293
   PubMed Web of Science ®Google Scholar
• CosterDJShepherdWFFookTCProlonged survival of corneal allografts in rabbits treated with cyclosporine ALancet19792688990771
   PubMed Web of Science ®Google Scholar
• HollandEJOlsenTWKetchamJMTopical cyclosporine A in the treatment of anterior segment inflammatory diseaseCornea19931241398306663
   PubMed Web of Science ®Google Scholar
• SahinABozkurtBIrkecMTopical cyclosporine A in the treatment of superior limbic keratoconjunctivitis: a long-term follow-upCornea200827193518216575
   PubMed Web of Science ®Google Scholar
• MatsudaSKoyasuSMechanisms of action of cyclosporineImmunopharmacology2000471192510878286
   PubMed Web of Science ®Google Scholar
• DjalilianARNagineniCNMaheshSPInhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporinCornea2006257091417077666
   PubMed Web of Science ®Google Scholar
• MatsudaSShibasakiFTakehanaKTwo distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activationEMBO Rep200014283411258483
   PubMed Web of Science ®Google Scholar
• YoshidaAFujiharaTNakataKCyclosporin A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in miceExp Eye Res199968541610328967
   PubMed Web of Science ®Google Scholar
• TatlipinarSAkpekEKTopical cyclosporin in the treatment of ocular surface disorderBr J Ophthalmol2005891363716170133
   PubMed Web of Science ®Google Scholar
• GunduzKOzdemirOTopical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren’s syndromeActa Ophthalmol (Copenh)199472438427825408
   PubMed Web of Science ®Google Scholar
• SallKNCohenSMChristensenMTAn evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eyeEye Contact Lens20063221616415689
   PubMedGoogle Scholar
• SalibGMMcDonaldMBSmolekMSafety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusisJ Cataract Refract Surg200632772816765793
   PubMed Web of Science ®Google Scholar
• SallKStevensonODMundorfTKTwo multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study GroupOphthalmology2000107631910768324
   PubMed Web of Science ®Google Scholar
• WangYOgawaYDogruMOcular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host diseaseBone Marrow Transplant20084129330217982500
   PubMed Web of Science ®Google Scholar
• RobertsCWCarnigliaPEBrazzoBGComparison of topical cyclosporine, punctual occlusion, and a combination for the treatment of dry eyeCornea200726805917667613
   PubMed Web of Science ®Google Scholar
• YenMTPflugfelderSCFeuerWJThe effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjectsAm J Ophthalmol20011313142311239863
   PubMed Web of Science ®Google Scholar
• PflugfelderSCSolomonADursunDDry eye and delayed tear clearance: “a call to arms”Adv Exp Med Biol20025067394312613986
   PubMed Web of Science ®Google Scholar
• TurnerKPflugfelderSCJiZInterleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsionCornea200019492610928765
   PubMed Web of Science ®Google Scholar
• MarshPPflugfelderSCTopical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndromeOphthalmology19991068111610201607
   PubMed Web of Science ®Google Scholar
• HongSKimTChungSHRecurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren’s syndromeJ Ocul Pharmacol Ther200723788217341155
   PubMed Web of Science ®Google Scholar
• Cordero-ComaMAnzaarFSobrinLSystemic immunomodulatory therapy in severe dry eye secondary to inflammationOcul Immunol Inflamm2007159910417558834
   PubMed Web of Science ®Google Scholar
• GeerlingGMaclennanSHartwigDAutologous serum eye drops for ocular surface disordersBr J Ophthalmol20048814677415489495
   PubMed Web of Science ®Google Scholar
• YoonKCHeoHImSKComparison of autologous serum and umbilical cord serum eye drops for dry eye syndromeAm J Ophthalmol2007144869217493572
   PubMed Web of Science ®Google Scholar
• Creuzot-GarcherCLafontainePOBrignoleF[Treating severe dry eye syndromes with autologous serum]J Fr Ophthalmol20042734651
   PubMed Web of Science ®Google Scholar
• OgawaYOkamotoSMoriTAutologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplant2003315798312692625
   PubMed Web of Science ®Google Scholar
• Noda-TsuruyaTAsano-KatoNTodaIAutologous serum eye drops for dry eye after LASIKJ Refract Surgery200622616
   PubMed Web of Science ®Google Scholar
• YoonKCImSKParkYGApplication of umbilical cord serum eyedrops for the treatment of dry eye syndromeCornea2006252687216633024
   PubMed Web of Science ®Google Scholar
• SolomonARosenblattMLiDQDoxycycline inhibition of interleukin-1 in the corneal epitheliumInvest Ophthalmol Vis Sci20004125445710937565
   PubMed Web of Science ®Google Scholar
• AkpekEKMerchantAPinarVOcular rosacea: patient characteristics and follow-upOphthalmology1997104186379373118
   PubMed Web of Science ®Google Scholar
• GilbardJPDry eye, blepharitis and chronic eye irritation: divide and conquerJ Ophthalmic Nurs Technol1999181091510633658
   PubMedGoogle Scholar
• HayashiYIshimaruNArakakiREffective treatment of a mouse model of Sjögren’s syndrome with eyedrop administration of anti-CD4 monoclonal antibodyArthritis Rheum20045029031015457459
   PubMed Web of Science ®Google Scholar
• BarabinoSRolandoMCamicionePSystemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory componentCornea2003229710112605039
   PubMed Web of Science ®Google Scholar
• AragonaPBucoloCSpinellaRSystemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren’s syndrome patientsInvest Ophthalmol Vis Sci2005464474916303936
   PubMed Web of Science ®Google Scholar